| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $390.3M | $362.3M | $339.3M |
| YoY Revenue Growth % | +7.7% | +6.8% | — |
| Gross Profit | $94.0M | $83.0M | — |
| Gross Margin % | 24.1% | 22.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$23.5M | -$65.0M | -$63.7M |
| Operating Margin % | -6.0% | -17.9% | -18.8% |
| Net Income (GAAP) | -$75.8M | -$109.9M | -$96.2M |
| EBITDA (Normalized) | -$9.8M | -$19.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$5.8M | -$19.7M | -$4.8M |
| Capital Expenditures (CapEx) | $17.1M | $56.5M | — |
| Free Cash Flow (FCF) | -$22.9M | -$76.2M | -$4.8M |
| FCF Margin % | -5.9% | -21.0% | -1.4% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $46.8M | $56.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$164.2M | -$95.3M | — |